Elazar M - Search Results

1

Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2.

Hagey RJ, Elazar M, Pham EA, Tian S, Ben-Avi L, Bernardin-Souibgui C, Yee MF, Moreira FR, Rabinovitch MV, Meganck RM, Fram B, Beck A, Gibson SA, Lam G, Devera J, Kladwang W, Nguyen K, Xiong A, Schaffert S, Avisar T, Liu P, Rustagi A, Fichtenbaum CJ, Pang PS, Khatri P, Tseng CT, Taubenberger JK, Blish CA, Hurst BL, Sheahan TP, Das R, Glenn JS. Hagey RJ, et al. Among authors: elazar m. Nat Med. 2022 Sep;28(9):1944-1955. doi: 10.1038/s41591-022-01908-x. Epub 2022 Aug 18. Nat Med. 2022. PMID: 35982307 Free PMC article.

2

Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication.

Elazar M, Cheong KH, Liu P, Greenberg HB, Rice CM, Glenn JS. Elazar M, et al. J Virol. 2003 May;77(10):6055-61. doi: 10.1128/jvi.77.10.6055-6061.2003. J Virol. 2003. PMID: 12719597 Free PMC article.

3

An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication.

Elazar M, Liu P, Rice CM, Glenn JS. Elazar M, et al. J Virol. 2004 Oct;78(20):11393-400. doi: 10.1128/JVI.78.20.11393-11400.2004. J Virol. 2004. PMID: 15452261 Free PMC article.

4

Simplified RNA secondary structure mapping by automation of SHAPE data analysis.

Pang PS, Elazar M, Pham EA, Glenn JS. Pang PS, et al. Among authors: elazar m. Nucleic Acids Res. 2011 Dec;39(22):e151. doi: 10.1093/nar/gkr773. Epub 2011 Sep 30. Nucleic Acids Res. 2011. PMID: 21965531 Free PMC article.

5

HCV NS5A inhibitors: the devil is in the details.

Elazar M, Glenn JS. Elazar M, et al. Gastroenterology. 2014 Aug;147(2):273-7. doi: 10.1053/j.gastro.2014.06.021. Epub 2014 Jun 27. Gastroenterology. 2014. PMID: 24976028 No abstract available.

6

Emerging concepts for the treatment of hepatitis delta.

Elazar M, Glenn JS. Elazar M, et al. Curr Opin Virol. 2017 Jun;24:55-59. doi: 10.1016/j.coviro.2017.04.004. Epub 2017 May 2. Curr Opin Virol. 2017. PMID: 28475945 Review.

7

Hepatitis delta infection - Current and new treatment options.

Elazar M, Koh C, Glenn JS. Elazar M, et al. Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):321-327. doi: 10.1016/j.bpg.2017.05.001. Epub 2017 May 22. Best Pract Res Clin Gastroenterol. 2017. PMID: 28774414 Review.

8

Combination of Novel Therapies for HDV.

Elazar M, Glenn JS. Elazar M, et al. Viruses. 2022 Jan 28;14(2):268. doi: 10.3390/v14020268. Viruses. 2022. PMID: 35215860 Free PMC article. Review.

9

A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication.

Einav S, Elazar M, Danieli T, Glenn JS. Einav S, et al. Among authors: elazar m. J Virol. 2004 Oct;78(20):11288-95. doi: 10.1128/JVI.78.20.11288-11295.2004. J Virol. 2004. PMID: 15452248 Free PMC article.

10

The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein.

Lee C, Ma H, Hang JQ, Leveque V, Sklan EH, Elazar M, Klumpp K, Glenn JS. Lee C, et al. Among authors: elazar m. Virology. 2011 May 25;414(1):10-8. doi: 10.1016/j.virol.2011.03.026. Epub 2011 Apr 22. Virology. 2011. PMID: 21513964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page